Research Infrastructure Programs News Today

A study from the laboratory of Dr. Hugo J. Bellen, a distinguished service professor at Baylor College of Medicine and a principal investigator at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital, has discovered that gain-of-function variants in the DOT1L gene cause a new disorder.

<p>A study from the laboratory of Dr. Hugo J. Bellen, a distinguished service professor at Baylor College of Medicine and a principal investigator at the <a href="file:///C:/Users/rxnatara/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/DJZEC7Z1/nri.texaschildrens.org">Jan and Dan Duncan Neurological Research Institute</a> (Duncan NRI) at Texas Children’s Hospital, has discovered that gain-of-function variants in the <...

Director for the Wisconsin National Primate Research Center job in Madison, Wisconsin with University of Wisconsin-Madison Office of Vice Chancellor for Research. Apply Today.

A list of open funding opportunities for worldwide NGOs working to prevent HIV/AIDS and continually assist persons living with HIV. Entries Open for

Proposals to expand domestic breeding of primates for research overlook several ethical, scientific and safety woes.

A list of open funding opportunities for NGOs worldwide working for HIV/AIDS Prevention and continuously supporting HIV-infected people. Youth Hub Seed

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.